z-logo
Premium
Synthesis of C‐14‐labeled novel IKK inhibitor: 2‐[ 14 C]‐ N ‐(6‐chloro‐9H‐pyrido [3,4‐b]indol‐8‐yl)‐3‐pyridinecarboxamide
Author(s) -
Li Yuexian,
Prakash Shimoga R.
Publication year - 2005
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.926
Subject(s) - chemistry , stereochemistry
2‐[ 14 C]‐ N ‐(6‐Chloro‐9H‐pyrido [3,4‐b]indol‐8‐yl)‐3‐pyridinecarboxamide ( 9A , also referred to as [ 14 C]‐PS‐1145) was synthesized from [ 14 C]‐paraformaldehyde in five steps in an overall radiochemical yield of 15%. The key intermediate 1‐[ 14 C]‐6‐chloro‐1,2,3,4‐tetrahydro‐ β ‐carboline was obtained by Pictet–Spengler cyclization of chlorotryptamine with [ 14 C]‐paraformaldehyde. Similar reactions were conducted with tryptamine to address the generality of the methodology. Copyright © 2005 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom